Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 230.60%326.28K | 178.48%146.93K | 262.32%113.9K | 402.25%44.96K | -74.14%98.69K | 52.76K | 31.44K | 8.95K | 868.46%381.67K | 39.41K |
| Selling and administrative expenses | 853.77%230.13K | 304.78%93.62K | 9,216.50%93.17K | --38.95K | -81.38%24.13K | --23.13K | --1K | --0 | 636.82%129.57K | --17.59K |
| -Selling and marketing expense | --16.99K | --16.24K | --0 | --215 | --0 | --0 | --0 | --0 | ---- | ---- |
| -General and administrative expense | 783.36%213.14K | 234.56%77.38K | 9,216.50%93.17K | --38.73K | -81.38%24.13K | --23.13K | --1K | ---- | 636.82%129.57K | --17.59K |
| Other operating expenses | 28.95%96.15K | 79.91%53.32K | -31.88%20.73K | -32.85%6.01K | -70.42%74.56K | --29.64K | --30.44K | --8.95K | 1,055.10%252.1K | --21.83K |
| Operating profit | -230.60%-326.28K | -178.48%-146.93K | -262.32%-113.9K | -402.25%-44.96K | 74.14%-98.69K | -52.76K | -31.44K | -8.95K | -868.46%-381.67K | -39.41K |
| Net non-operating interest income (expenses) | 62.29%-411 | 27.36%-154 | 85.41%-62 | 61.98%-146 | -86.96%-1.09K | -212 | -425 | -384 | -106.01%-583 | -283 |
| Non-operating interest expense | -62.29%411 | -27.36%154 | -85.41%62 | -61.98%146 | 86.96%1.09K | --212 | --425 | --384 | 106.01%583 | --283 |
| Other net income (expenses) | -67 | |||||||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---67 |
| Income before tax | -227.40%-326.69K | -177.66%-147.09K | -257.68%-113.96K | -383.15%-45.1K | 73.90%-99.78K | -52.98K | -31.86K | -9.34K | -861.40%-382.25K | -39.76K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -227.40%-326.69K | -177.66%-147.09K | -257.68%-113.96K | -383.15%-45.1K | 73.90%-99.78K | -52.98K | -31.86K | -9.34K | -861.40%-382.25K | -39.76K |
| Net income continuous operations | -227.40%-326.69K | -177.66%-147.09K | -257.68%-113.96K | -383.15%-45.1K | 73.90%-99.78K | ---52.98K | ---31.86K | ---9.34K | -861.40%-382.25K | ---39.76K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -227.40%-326.69K | -177.66%-147.09K | -257.68%-113.96K | -383.15%-45.1K | 73.90%-99.78K | -52.98K | -31.86K | -9.34K | -861.40%-382.25K | -39.76K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -227.40%-326.69K | -177.66%-147.09K | -257.68%-113.96K | -383.15%-45.1K | 73.90%-99.78K | -52.98K | -31.86K | -9.34K | -861.40%-382.25K | -39.76K |
| Diluted earnings per share | -200.00%-0.03 | 13.09%-0.0048 | -11.97%-0.0037 | -51.23%-0.0015 | 74.87%-0.01 | -0.0055 | -0.0033 | -0.001 | -861.30%-0.0398 | -0.0041 |
| Basic earnings per share | -200.00%-0.03 | 13.09%-0.0048 | -11.97%-0.0037 | -51.23%-0.0015 | 74.87%-0.01 | -0.0055 | -0.0033 | -0.001 | -861.30%-0.0398 | -0.0041 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.